Epidemiological Features of Cardiovascular Disease in Asia
State-of-the-art Review
Central Illustration
Abstract
Cardiovascular disease (CVD) is the leading cause of death in Asia. To combat the harmful impacts of CVD on public health in Asian countries with more effective strategies and actions, it is crucial to understand the current epidemiologic features of CVD in Asia. Through a systematic study and analysis of various timely data on CVD epidemiology in Asian countries from multiple sources, this state-of-the-art review provides an overview of the important epidemiologic features of CVD in Asia. Current and future challenges in CVD prevention implied by the epidemiologic features in Asian countries are highlighted and discussed in this review.
Highlights
| • | Comprehensive data for the current features of CVD epidemics in Asia are lacking. | ||||
| • | This review provides an overview of the epidemiologic features of CVD in Asia. | ||||
| • | Current and future challenges and requirements for CVD prevention in Asian countries are addressed. | ||||
References
1. "Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017". Lancet 2018;392:1736-1788.
2. "Global Burden of Disease Study 2019 (GBD 2019) Results". Seattle, WA: Institute for Health Metrics and Evaluation (IHME), 2020. Available at: http://ghdx.healthdata.org/gbd-results-tool. Accessed
May 1, 2021 .3. "Global age-sex-specific fertility, mortality, healthy life expectancy (HALE), and population estimates in 204 countries and territories, 1950–2019: a comprehensive demographic analysis for the Global Burden of Disease Study 2019". Lancet 2020;396:1160-1203.
4. "Department of Economic and Social Affairs, Population Division, United Nations. World Population Prospects 2019". Available at: https://population.un.org/wpp/. Accessed
May 1, 2021 .5. "World Health Statistics 2020: monitoring health for the SDGs, sustainable development goals". Geneva: World Health Organization, 2020. Available at: https://www.who.int/publications/i/item/9789240005105. Accessed
May 1, 2021 .6. "The impact of poverty reduction and development interventions on non-communicable diseases and their behavioural risk factors in low and lower-middle income countries: a systematic review". PLoS One 2018;13:e0193378.
7. "Age- and sex-specific burden of cardiovascular disease attributable to 5 major and modifiable risk factors in 10 Asian countries of the Western Pacific region". Circ J 2015;79:1662-1674.
8. "Cardiovascular disease epidemiology in Asia". Circ J 2013;77:1646-1652.
9. "Global, regional, and national burden of cardiovascular diseases for 10 causes, 1990 to 2015". J Am Coll Cardiol 2017;70:1-25.
10. "Global, regional, and national age-sex specific mortality for 264 causes of death, 1980–2016: a systematic analysis for the Global Burden of Disease Study 2016". Lancet 2017;390:1151-1210.
11. "Epidemiology of cardiovascular disease in China: current features and implications". Nat Rev Cardiol 2019;16:203-212.
12. "Epidemiological transition of stroke in China: twenty-one-year observational study from the Sino-MONICA-Beijing Project". Stroke 2008;39:1668-1674.
13. "ASIAN-F Investigators. Regional variation of mortality in heart failure with reduced and preserved ejection fraction across Asia: outcomes in the ASIAN-HF Registry". J Am Heart Assoc 2020;9:e012199.
14. "Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis". Lancet Glob Health 2019;7:e1020-e1030.
15. "The epidemiologic transition: a theory of the epidemiology of population change". Milbank Mem Fund Q 1971;49:509-538.
16. "Global burden of cardiovascular diseases: part I: general consideration, the epidemiology transition, risk factors and impact of urbanization". Circulation 2001;104:2746-2753.
17. "The epidemiologic transition: changing patterns of mortality and population dynamics". Am J Lifestyle Med 2009;3:Suppl: 19S-26S.
18. "Synthesis and implications: China nutrition transition in the context of changes across other low- and middle-income countries". Obes Rev 2014;15:Suppl 1: 60-67.
19. "Health effects of dietary risks in 195 countries, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017". Lancet 2019;393:1958-1972.
20. "2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)". Eur Heart J 2016;37:2315-2381.
21. "A global review of food-based dietary guidelines". Adv Nutr 2019;10:590-605.
22. "Global statistics on alcohol, tobacco and illicit drug use: 2017 status report". Addiction 2018;113:1905-1926.
23. "Global, regional, and national comparative risk assessment of 79 behavioral, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015". Lancet 2016;388:1659-1724.
24. "Long-term incidence and risk factors of cardiovascular events in Asian populations: systematic review and meta-analysis of population-based cohort studies". Curr Med Res Opin 2019;35:291-299.
25. "Smokeless tobacco and cardiovascular disease in low and middle income countries". Indian Heart J 2013;65:369-377.
26. "Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults". Lancet 2017;390:2627-2642.
27. "Association between body mass index and cardiovascular disease mortality in east Asians and south Asians: pooled analysis of prospective data from the Asia Cohort Consortium". BMJ 2013;347:f5446.
28. "A comparative analysis of risk factors and stroke risk for Asian and non-Asian men: The Asia Pacific Cohort Studies Collaboration". Int J Stroke 2013;8:606-611.
29. "Mortality, morbidity, and risk factors in China and its provinces, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017". Lancet 2019;394:1145-1158.
30. "Current status of adherence interventions in hypertension management in Asian countries: a report from the HOPE Asia Network". J Clin Hypertens (Greenwich) 2020Dec17. [E-pub ahead of print].
31. "Asian management of hypertension: current status, home blood pressure, and specific concerns in Pakistan". J Clin Hypertens (Greenwich) 2020;22:501-503.
32. "China Hypertension Survey Investigators. Status of hypertension in China: results from the China Hypertension Survey, 2012-2015". Circulation 2018;137:2344-2356.
33. "Asian management of hypertension: current status, home blood pressure, and specific concerns in Malaysia". J Clin Hypertens (Greenwich) 2020;22:497-500.
34. "Repositioning of the global epicentre of non-optimal cholesterol". Nature 2020;582:73-77.
35. "Prevalence of dyslipidemia and achievement of low-density lipoprotein cholesterol targets in Chinese adults: a nationally representative survey of 163,641 adults". Int J Cardiol 2018;260:196-203.
36. "Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4.4 million participants". Lancet 2016;387:1513-1530.
37. "Diabetes in Asia". Lancet 2010;375:408-418.
38. "Association of diabetes with all-cause and cause-specific mortality in Asia: a pooled analysis of more than 1 million participants". JAMA Netw Open 2019;2:e192696.
39. "Burden and risk factors of diabetes and hyperglycemia in India: findings from the Global Burden of Disease Study 2016". Diabetes Metab Syndr Obes 2018;11:381-387.
40. "Multimorbidity patterns and 6-year risk of institutionalization in older persons: the role of social formal and informal care". J Am Med Dir Assoc 2021Feb5. [E-pub ahead of print].
41. "Health care utilization in older people with cardiovascular disease in China". Int J Equity Health 2015;14:59.
